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DAbstract
We have established an in vivo system to investigate mechanisms by which
pentobarbital (PB), a psychoactive drug with a sedative effect, changes the rate
of decay of gstD21 mRNA (encoding a Drosophila glutathione S-transferase).
Here we describe methods for the use of hsp70 promoter-based transgenes and
transgenic lines to determine mRNA half-lives by RNase protection assays in
Drosophila. We are able to identify and map putative decay intermediates
by cRT-PCR and DNA sequencing of the resulting clones. Our results indicate
that the 30-UTR of gstD21 mRNA is responsive to PB by regulating mRNA decayods in Enzymology, Volume 448 # 2008 Elsevier Inc.
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286 Bu¨nyamin Akgu¨l and Chen-Pei D. Tuand that the cis-acting element(s) responsible for the PB-mediated stabilization
resides in a 59 nucleotide sequence in the 30  -UTR of the gstD 21 mR NA (Akgu¨ l
and Tu, 2007).
1. Introduction
Xenobiotics and drugs affect gene expression at different levels, including
mRNA stability (Akgu¨l and Tu, 2005; Ko¨hle and Bock, 2007; Nakata et al.,
2006).We have reported that the sedative drug pentobarbital (PB) can stabilize
the mRNA of an intronless gene encoding glutathione S-transferase (gst) D21
in Drosophila melanogaster (Akgu¨l and Tu, 2004, 2007; Tang and Tu, 1995).
The mechanism(s) by which PB may affect mRNA stability are not clear.
Since cultured cells usually do not respond well, if at all, to psychoactive drugs
like PB, we needed to develop a simple in vivo system to investigate
the mechanism by which PB affects gstD21 mRNA stability. We chose the
Drosophila system over the rodents because of the intronless nature of
the gstD21 gene and the relative ease of maintenance and manipulation.
With theDrosophila system, we have at our disposal genetic and molecu-
lar tools such as transposition mutagenesis, siRNA technology, and an
extensive collection of mutants generated by p-element insertions, classical
mutagenesis, and other approaches (Rubin, 1988). On establishing an in vivo
PB-responsive system for analyzing RNA decay, we can generate transfor-
mant flies with various designer (e.g., deletion and chimeric) constructs and,
in these rendered contexts, identify in the mRNA sequences cis-acting
elements important for RNA decay.
The major challenge to study RNA turnover in a whole organism is to
devisemethod(s) that selectively and quickly activate transcription of the target
gene to a very high level, followed by rapid shut-off of gene activation for
monitoring the decay rate of the target mRNA under normal or well-
controlled physiologic state of the organism. For the Drosophila system, we
chose the hsp70 promoter to activate target transgene expression at 35 C.
When heat shock factor associates with the hsp70 promoter on heat shock
(HS), the pausing RNA polymerase II complex at the promoter is immedi-
ately released for elongation. The promoter returns to the uninduced state
within less than 60min after removal of heat shock (Tang et al., 2000), and the
organism quickly returns to the normal physiologic state. These attributes
make the HS-responsive hsp70 promoter suitable for use in studying RNA
decay in vivo. In the following, we describe a system to investigate mRNA
decay under the effects of PB using the gstD21 mRNA as the reporter.
Furthermore, by incorporating the chimeric gene approach, we are able to
dissect the D21 mRNA for the cis-acting elements responsible for drug-
mediated stabilization of gstD21 mRNAs inDrosophila (Akgu¨l and Tu, 2007).
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2.1. Materials
Bacteriologic media were purchased from Invitrogen/Life Technologies
(Rockville, MD), and chemicals from ICN, Life Technologies or
Sigma-Aldrich (St. Louis, MO). Sodium pentobarbital was purchased from
Sigma-Aldrich.Oligonucleotides were obtained from IntegratedDNATech-
nologies, Inc. (Coralville, IA). Radioactive nucleotides ([a-32P] UTP, specific
activity 800 mCi/mmol) were purchased from ICN (Irvine, CA). RPA III
kits were purchased from Ambion (Austin, TX). Restriction enzymes were
products of New England Biolabs (NEB) (Beverly, MA) or American Allied
Biochemicals (Aurora, CO). Pfu DNA polymerase and Quick-change
Ò
site-
directedmutagenesis kit were purchased from Stratagene (SanDiego,CA). T4
DNA ligase, MMLV-reverse transcriptase, SP6 RNA polymerase and the
plasmid vectors pGEM T Easy
Ò
and pSP64(A) for in vitro transcription were
purchased from Promega (Madison,WI). Tobacco acid phosphatase was from
Epicentre Technologies (Madison,WI). T7RNA polymerase was a generous
gift from Bi-ChengWang (University of Georgia, Athens, GA). E. coliDH5a
competent cells andPfxDNApolymerasewere products of LifeTechnologies.
The plasmid vector pCaSpeR-hs-act for Drosophila transformation was
obtained from C. S. Thummel of the University of Utah (Thummel et al.,
1988). The △2-3 line {P[ryþ 2-3](99B)} (Robertson et al., 1988) expressing
transposase and the yw line were obtained from Susan Abmayr and David
Gilmour, respectively, both of theDepartment ofBiochemistry andMolecular
Biology, The Pennsylvania State University (University Park, PA). All glass-
ware used inRNAwork is baked at 180 Covernight. All solutions except for
Tris buffers are treated with 0.1% DEPC (Sigma) overnight under a hood and
autoclaved for 15 min and placed under the hood at least for 5 h to evaporate
the residual DEPC in the solutions. Because DEPC changes the chemical
structure of Tris, the stock solutions are prepared first with DEPC-treated
water and then filtered through a 0.22-mmNalgene filter.
2.2. Transgenic constructs and nomenclature
We use small plasmid vectors pBluescript or pGEM T Easy (Promega)
for initial cloning of PCR products and manipulation of gene segments
before transferring the chimeric DNA constructs into the transformation
vector pCaSpeR-hs-act (Thummel et al., 1988). Site-directed mutagenesis
and swapping of DNA fragments between homologous genes can be accom-
plished more easily with small plasmids. When we need a restriction site in
the coding region to facilitate DNA fragment swapping, we introduce base
changes that conserve the amino acid sequence to minimize any possible
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(e.g., the swapping at nucleotide 567 in Fig. 15.1, D21-170-D1). We then
use site-directed mutagenesis to restore some mutations back to the wild-
type sequence. A typical reaction contains 30 to 50 ng of double-stranded
template DNA, 300 nM of each of the two primers, 0.2 mM dNTPs, 1 Pfu
DNApolymerase buffer, and 2.5U PfuDNApolymerase (Stratagene). PCR
conditions are as follows: 1 cycle of 94 C for 1 min; 18 cycles of 94 C for
30 sec, 55 C for 1 min, and 68 C for 11 min. The PCR product is then
digested with 1 U ofDpn I to remove the methylated template DNA, and an
aliquot is used for transformation (Sambrook and Russell, 2001).
Once the desired constructs in pBluescript or pGEM T Easy are gener-
ated and their sequences confirmed, a pair of primers with appropriate
restriction sites at the 50-ends is used to amplify the inserted DNA for
cloning into the pCaSpeR-hs-act transformation vector (Thummel et al.,
1988). Inclusion of a few additional nucleotides 50-to the restriction sites on
the PCR primers facilitates complete digestion of the amplified products
(Moreira and Noren, 1995). We use commercial fragment isolation kits to
purify the restriction enzyme-digested PCR products for further manipula-
tions. The pCaSpeR-hs-act transformation vector has eight unique restric-
tion sites in the multiple cloning site (MCS) sequences. We typically use the
BamHI and EcoRI sites for DNA insertions so that the extraneous MCS1 780
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gstD21
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Figure 15.1 Transgenic constructs of gstD21. Nucleotides (nts) 1 to 780 represent the
complete gstD21(L) mRNA sequence (50-UTR, nts 1 to 52; coding region, nts 53 to 699;
30-UTR, nts 700 to 762 for S form and nts 700 to 780 for the L form) (Akg€ul and Tu,
2004). EachtransgenicRNAshouldhave the sameheterologousUTRcontext, containing
the 50-UTRof hsp70 and the 30-trailer of actin 30-UTR. Open boxes represent the gstD21
protein-coding region.The native 50-UTRof gstD21mRNA is represented by a checkered
boxpreceding the proteincoding region,and the native 30-UTR is specifiedbya solid box.
The gstD1 (nt 567 to 699) sequence in the chimeric genes D21-170-D1 and D21-170-D1 þ
D21UTR are shown in cross-hatched boxes. Pentobarbital-mediated stabilization of a
givenD21transgenicmRNAis indicatedbyaYesorNo.
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heterologous sequence context by having the hsp70 50-UTR and the trailer
region of the actin5C’s 30-UTR. The 50-UTR of the hsp70 should afford
optimum translation under heat shock conditions, and by doing so any
potential effect of translation on the stability of the transgenic mRNAs may
be avoided or minimized.
2.2.1. Microinjection and establishment of transgenic lines
We follow the procedure of Thummel et al. (1998) for Drosophila transfor-
mation, which is a modification of the initial approach demonstrated by
Rubin and Spradling (1982 and 1983). We will limit the discussion of
Drosophila transformation to those that apply to our results. Plasmid DNAs
(chimeric genes on pCaSpeR-hs-act vector) should be of the highest
possible purity for decent transformation efficiency. We use DNA prepara-
tions (Qiagen Midi Plasmid DNA preparation kit) at 0.5 mg/ml in ddH2O
and with an A260/A280 ratio of 1.8 for transformation. We collect embryos
at room temperature of 23 to 25 C for 45 min, but microinjection is carried
out in an 18 C room, and the procedure is completed within 45min after the
embryo harvest. The glue used to line up the embryos on the microscope
cover slip is prepared by vortex-mixing double-sided Scotch adhesive tape in
n-hexane. The hexane supernatant is then empirically adjusted to the appro-
priate viscosity in 1.5-ml microcentrifuge tubes before use. We avoid the use
of any dyemarker in the DNA solution to optimize transformation efficiency;
the injection can be easily visualized by a slight postinjection disturbance at the
posterior end of the embryo. We minimize the number of nontransformants
by use of the injection needle to smash the aged (cellularized) or uninjected
embryos.
The newly eclosed G0 flies are crossed individually to yw to remove any
background transposase. All the female flies used in crosses are virgins.
Yellow-eyed to red-eyed G1 progeny with longer body bristles (Sb
-) are
recrossed with yw. Each stable line is established through sibling crosses of
colored-eyed G2 flies. On average, for each DNA construct, we inject 300
embryos, of which 10% reach adulthood with 25% being transformants. We
typically maintain at least three separate lines for each transgene construct.
By our design, we use heat shock to induce the transgenes driven by the
hsp70 promoter, whereas the endogenous gstD21 gene is induced by PB
(Akgu¨l and Tu, 2004). Therefore, increases in the level of transgene-derived
mRNAs upon simultaneous treatment with HS and PB (HSPB-treated)
that are detected beyond that by HS alone, could be attributed to stabiliza-
tion of the transgenic gstD21 mRNA by PB. When combined treatment is
intended, it should be ensured that the endogenous gene is not induced by
heat shock.
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Pentobarbital (PB) regulates gst gene expression at both the transcriptional
and posttranscriptional levels (Tang and Tu, 1995). Because of PB’s water
solubility, we chose this xenobiotic as a model drug to identify cis-acting
determinants responsible for drug-induced changes of gstD21 mRNA sta-
bility. We discuss the procedure for PB and heat shock treatment of flies in
this section.
Adult flies maintained on a standard cornmeal medium (Tang and Tu,
1994) (2- to 3-day-old, 150 to 200 flies per bottle) are starved for 5 h in
clean milk bottles with foam plugs at room temperature. We place a strip
(3  10 cm) of 3MM paper saturated (800 ml solution per strip) with
either a 5% sucrose solution (control flies) or 200 mg/ml PB in 5% sucrose
(PB-treated flies) in each bottle for the treatment for 2 h at room tempera-
ture. We avoid the use of dripping strips because the flies become stuck to
the bottle wall (thus lower recovery). For a time-course analysis of RNA
decay (e.g., calculation of the half-life of a given chimeric mRNA), flies are
treated with PB for 2 h and then transferred to clean milk bottles containing
a 3MM paper strip saturated with a 5% sucrose solution for 0 (control), 0.25,
0.5, 1, 2, 3, 4, 8, 10, and 12 h.
Heat shock of flies is carried out in milk bottles (150 to 200 flies per
bottle) at 35 C for 1 h in a hybridization oven (Model 2000, Micro-
hybridization incubator, Robbins Scientific Company, Sunnyvale, CA). A
3MM paper strip saturated with a 5% sucrose solution (800 ml) is placed in
the bottles during the HS treatment to prevent dehydration of the flies. Two
strips are used per bottle when HS treatment is performed at elevated
temperatures (e.g., 37 C). (An empty milk bottle with a foam plug requires
15 min to reach 35 C from room temperature and takes 6 min to drop
to 31 C after removal of the bottle from the 35 C oven.) The extent of
chimeric mRNA induction can be adjusted by controlling HS temperatures
(e.g., elevated expression of transgenes at 37 C relative to 35 C). To
minimize variations of temperature for HS treatment, different lines of
transgenic flies to be compared in the same experiment are heat-shocked
at the same time. To concurrently overexpress D21 transgene (heat shock-
inducible) and endogenous gstD21 (PB-inducible) mRNAs, the flies are
treated with PB at room temperature for 1 h and then at 35 C for the
second hour (Akgu¨l and Tu, 2002). For a time-course study, the flies are
transferred, after the treatment, into clean milk bottles containing 3MM
paper strips saturated with a 5% sucrose solution kept at room temperature.
Flies are collected in liquid nitrogen–treated 250-ml wide-mouth centri-
fuge bottles, snap-frozen with copious amounts of liquid nitrogen, and
stored in 15-ml polypropylene tubes at 80 C until use. We avoid the
use of polystyrene tubes for storing flies as they easily crack in liquid
nitrogen.
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Despite the availability of many rapid RNA isolation kits, we have consis-
tently obtained excellent yield with high-quality RNA from both embryos
and adults by following the procedure of Ullrich et al. (1977). Up to 2 mg of
total-fly RNA can be isolated from 1 g of frozen flies. We prefer to use
guanidine hydrochloride over guanidine isothiocyanate in the homogeni-
zation buffer because the former is easier to dissolve. This procedure is not
appropriate for isolating RNAs smaller than 200 nt, because they do not
efficiently cosediment with the high-molecular-weight RNAs (www.
ambion.com). Typically, 0.5 to 1 g of frozen flies or embryos are
homogenized in 7 ml of lysis buffer (4 M guanidinium hydrochloride, 1
M b-mercaptoethanol, 0.1MNaOAc, pH 5, and 0.01M EDTA) in a 15-ml
Douce homogenizer first with Pestle B (20 strokes) and then with Pestle A
(10 strokes). CsCl (1.05 g) is added per ml of the homogenate until it is
fully dissolved at room temperature. The solution (8 ml) is then
transferred into a clear ultracentrifuge tube underlaid with 2 ml of DEPC-
treated, cushion solution (saturated CsCl solution containing 10 mM EDTA
and 50 mM NaOAc, pH 5). The mixture is then centrifuged at room
temperature in a Beckman Ti70.1 rotor at 139,000g for 25 h. The flaky
RNA visible to the naked eye below a non-UV–absorbing thick band is
drawn with a 1-ml syringe with an 18-gauge needle. The RNA in CsCl
solution 1 ml per tube is diluted with 3 volumes of DEPC-treated water
before ethanol (2.5 volumes) precipitation in a Corex tube (15 ml or 30 ml).
The RNA is collected by centrifugation at 13,000 rpm at 4 C in a swinging
bucket rotor (e.g., Sorvall HB4). The RNA dissolved in DEPC-treated
water is aliquoted to prevent subsequent multiple freeze-and-thaw cycles.
The quality of RNA prepared by this method survives long-term storage
(80 C) without any degradation for up to 3 y.
To monitor changes in the expression of a specific chimeric gst mRNA,
we have reliably used the ribonuclease protection assay (RPA) (Calzone
et al., 1987). It is feasible to assess the quantity, as well as the ends of a
transcript (e.g., alternatively polyadenylated mRNAs) (Fig. 15.2A) by this
method. In addition, we can simultaneously analyze multiple RNA species
with cRNA probes of different lengths (e.g., Akgu¨l and Tu, 2002; 2004) by
following Ambion’s instructions for RPA assays. Riboprobes (cRNAs) are
prepared from linearized plasmid DNAs containing the target sequences in
the antisense orientation cloned downstream of a T7 or SP6 RNA poly-
merase promoter. We obtain excellent radiolabeled in vitro transcripts with
0.5 mg linearized plasmid DNA according to Promega’s instructions. Only
the mRNA sequences perfectly complementary to the radioactive ribop-
robe would be protected from the subsequent RNase digestions. We
prepare riboprobe clones from DNAs of the chimeric plasmids used for
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Figure 15.2 RNase protection assay analysis of pentobarbital-stabilized D21 tran-
scripts.PentobarbitaltreatmentandRPAanalysiswereperformedas indicated in‘‘Pento-
barbitalTreatment’’and ‘‘RNA Isolation and RPA Analyses’’sections.The RPA analysis
was carried out with 40 mg of total-flyRNAand a radiolabeled D21.AS.SmaI riboprobe.
(A)TheriboprotectedD21fragmentswereresolvedinan8%denaturingpolyacrylamide
gel. M, a radiolabeled in vitro^transcribed RNAmarkers, with sizes shown to the left of
thepanel.Endo-D21LandEndo-D21S,theL(long)andtheS(short) formsoftheendoge-
nous gstD21mRNAs, respectively; RP-49, the endogenous control ribosomal protein 49
mRNA. (B)mRNAamounts in (A)were normalized against the level of RP-49mRNA
(upperband)andexpressed relativetothecontrol level (100%).
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preparation must be correctly sequenced, because a single nucleotide differ-
ence would result in unhybridized bases that could be subjected to RNase
cleavage and generation of partially ribo-protected fragments.
We typically use 20 to 40 mg of total-fly RNA in each RPA reaction to
analyze gstD21 mRNA decay. However, less RNA would suffice if the
expression level of the mRNA is relatively higher. The riboprobe-protected
products are analyzed by denaturing polyacrylamide gel electrophoresis
(0.75-mm thick, 8%, 19:1), followed by exposure in a PhosphorImager
cassette for 1 to 5 h at room temperature depending on the intensity of the
signal(s). The relative amount of each mRNA is then quantified. Phosphor-
Imager signals are normalized against an endogenous reference mRNA (e.g.,
RP-49) (O’Connell andRosbash, 1984). There is no need for drying the gel,
because riboprobes with high specific activity are generated through in vitro
transcription in the presence of [a-32P] UTP (800 mCi/mmol). The cRNA
probe is purified through a 6% denaturing polyacrylamide gel and extraction
buffer (Ambion) and is included at levels threefold to fourfold (determined
mRNA Half-Life Measurement in Drosophila 293empirically) in excess to the target mRNA. Although one preparation of
radioactive probes is sufficient formore than 100 reactions, prolonged storage
at80 C over 2 days results in undesirable smears in RPA signals, presum-
ably because of radiation-induced breakage of the probe.
2.5. Determining 50- and/or 30-ends and decay intermediates
of gstD21 mRNAs
This method is based on circularization of decapped mRNAs followed by
RT-PCR (Couttet et al, 1997) (Also see Chapter 22 by Grange). Although
several methods are available to identify the 50- or 30-end of an mRNA
individually, we have successfully used circular RT-PCR to simultaneously
map both ends of various gstD21s at the nucleotide level (Akgu¨l and Tu,
2007). It has been particularly useful in mapping multiple gstD21 decay
intermediates at the nucleotide level. We first use a nested set of radioactive
probes in RPA analyses to roughly estimate the ends of the intermediates
(Akgu¨l and Tu, 2007). These results are then used as a guide in designing the
appropriate pair of primers (50 nt from the ends) for the subsequent RT-
PCR experiment. This procedure can also be used to determine the length
of the poly(A) tail of an mRNA, if desired (Couttet et al, 1997).
For cRT-PCR reactions, we treat 10 mg of total RNA with 1 U of
RNase-free DNase (Promega) for 20 min at 37 C in 50 ml of 50 mM Tris-
HCl, pH 7.5, and 10 mM MgCl2 to remove any residual genomic DNA
contamination. After phenol-chloroform (Ambion) extraction twice and
ethanol (RNase-free absolute alcohol) precipitation and a 70% ethanol
wash, half of the recovered RNA is treated with 2.5 U of TAP (tobacco
acid pyrophosphatase) in the presence of 20 U of RNasin, 50 mMNaOAc,
pH 6, 1% b-mercaptoethanol, 1 mM EDTA, 0.1% Triton X-100 in 20 ml
final volume for 60min at 37 C. The decappedRNA is phenol-chloroform
extracted twice, ethanol-precipitated, and circularized with 20 U of T4
RNA ligase (Pharmacia), 50 mM Tris-HCl, pH 7.5, 10 mM MgCl2, 20
mMDTT, 100 mMATP, 100 mg/ml acetylated BSA, and 20U of RNasin in
400 ml volume at 16 C for 16 h. The circularized RNA is extracted with
phenol-chloroform twice and ethanol precipitation as before. Then, cDNA
is prepared by reverse transcription with MLV-RT and 10 ng of a gene-
specific 18-mer primer. The resulting cDNA reaction mixture should be
boiled for 5 min before digestion with a mixture of RNase A andRNase T1.
The treated cDNA is recovered by phenol-chloroform extraction once and
ethanol precipitation. One percent of the recovered cDNA is used for PCR
amplification. The PCR product is gel-purified and cloned into pGEM T
Easy vector (Promega). Cloned plasmid DNAs are randomly selected for
sequence analysis to determine the 50- and/or 30-ends of the mRNAs. We
sequenced 100 clones to obtain a distribution of the ends of RNA decay
intermediates of gstD21 mRNA (Akgu¨l and Tu, 2007).
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D21 mRNA levels are normalized relative to the endogenous RP-49
mRNA levels. All values are subsequently determined relative to the ratio
obtained in the control lines (e.g., no HS and/or PB treatment), which is
designated as 100% expression. Because PB remains in the gut of the flies
and thus continues to induce gstD21 expression more than 2 h after the
cessation of the PB treatment (Fig. 15.2B), we use the time points between
3 and 10 h for half-life calculations. The log of the relative (% mRNA) level
is plotted against time after treatment to obtain a linear regression trend line
(Fig. 15.3). The half-life is then calculated from the formula t1/2¼0.693/
k (min), where k¼2.303(m). The slope, m, is obtained from the trend line
(y ¼ mx þ b). An example of such a calculation is presented in Fig. 15.3,
where log (% mRNA) of HS-induced D21-170-D1 mRNA are plotted
against recovery time (in min). The t1/2 for the D21-170-D1 chimeric
RNA is calculated to be 3.5 h.
To assess whether the native D21 30-UTR has a cis-acting element for
stabilizing D21 mRNA in the presence of PB, we prepare two constructs
with andwithout theUTR (e.g.,D21-170-D1vsD21-170-D1þD21UTR
in Fig. 15.1). The t1/2 of both transgenic D21 mRNAs is subsequently
calculated under HS and HSPB conditions. If the D21 native UTR contains
a cis-acting stabilizing element, the t1/2 is expected to be similar for the
reporter transcript without the UTR (D21-170-D1 in Fig. 15.1), whereas
the reporter transcript with the UTR (D21-170-D1 þ D21UTRD21-170-D1 (HS)
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Figure 15.3 Calculations ofmRNAhalf-lives fromthe time-course data. On the basis
of RPAanalyses (Fig.15.2A), we plot log[%mRNA] vsminutes recovery time, defining
the value at zero time as 100%.We used linear regression to find a best-fit straight line
(y ¼ mx þ b; m is the slope) for data obtained between 3 and 10 h.The half-life (t1/2) is
derived from the equation: t1/2 ¼ 0.693/k, where k ¼ 2.303m.This is a representative
plot for calculating the t1/2 of the HS-induced D21-170-D1 transgenic mRNA (Fig. 15.1).
From the best-fit regression line, t1/2 ¼ 0.693/(2.303)(0.0014) ¼ 213 (min), where m is
equal to 0.0014.We typically use at least three different fly populations for each treatment
(e.g., heat shock or combined heat shock and PB treatment) and carry out three RPA
analyses fromeachoftwoindependentRNAisolations (i.e., atotalofsixRPAanalyses).
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compared with HS conditions (Akgu¨l and Tu, 2004; 2007).
Our previous results suggest that PB stabilizes the gstD21 mRNA (Tang
and Tu, 1995). To identify the cis-acting determinant(s) responsible for PB-
mediated stabilization, we first deleted the 30-UTR of the gstD21 mRNA
(Fig. 15.1, D21L-UTR) and found that this particular chimeric D21 tran-
script is unresponsive to PB treatment (i.e., no stabilization by PB) (Akgu¨l
and Tu, 2004). Reinsertion of the native 30-UTR of gstD21 restored the
PB-mediated stabilization (Akgu¨l and Tu, 2004). We also detected a series
of decay intermediates, Int-D21L (Fig. 15.1), which lacked the 30-UTR as
mapped by cRT-PCR. These putative decay intermediates were not sta-
bilized by PB, supporting the notion that a PB-responsive element is present
in the 30-UTR of the gstD21 mRNA (Akgu¨l and Tu, 2007).
We then used a reporter transcript (Fig. 15.1, D21-170-D1, originally
constructed to study translational regulation of gstD21 mRNA) to test the
effect of the gstD21 30-UTR on the stability of the resulting chimeric D1-
D21 mRNA (Fig. 15.1, D21-170-D1 þ D21UTR) in the presence of PB.
RPA analyses showed that insertion of the gstD21 30-UTR conferred PB-
responsiveness to the otherwise PB-nonresponsive D21-170-D1 reporter
mRNA (Akgu¨l and Tu, 2007). Although the preceding approach is specifi-
cally focused on identifying the PB-responsive cis element in the gstD21
mRNA, a similar strategy could be implemented to isolate cis elements in
any mRNA.
3. Concluding Remarks
Much of our current understanding of the pathways of mRNA
degradation in eukaryotic cells came from studies in S. cerevisiae and in
mammalian cells (Caponigro and Parker, 1996; Isken and Maquat, 2007;
Jacobson and Peltz, 1996; Ross, 1995). Commonly used methods for
measuring mRNA half-lives include approach to steady-state method,
transcriptional pulse-chase, drug inhibition of transcription, inhibition of
transcription by regulated promoters, and short-term promoter activation.
In vitro systems for mRNA turnover have also been developed (Ross, 1993).
None of these systems are applicable to investigating mechanisms of drug-
induced changes in mRNA stability.
By use of hsp70 promoter-based transgenes and transgenic lines, we have
established a Drosophila system to investigate PB-mediated changes in
mRNA decay using the gstD21 mRNA. This approach has been quite
useful not only in dissecting the gstD21 RNA for cis-acting element(s)
responsible for the changes in mRNA stability by PB treatment but also
in explaining alternative polyadenylation of gstD21 mRNA (Akgu¨l and
296 Bu¨nyamin Akgu¨l and Chen-Pei D. TuTu, 2002; 2004; 2007). Our analysis suggests that the cis-acting element
responsible for the PB-mediated stabilization resides in a 59 nucleotide
sequence within the gstD21 mRNA 30-UTR (Akgu¨l and Tu, 2007).
Further dissection of this PB-responsive region will allow the identification
of trans-acting factors essential for the drug’s effect on gstD21 mRNA at the
level of RNA turnover.
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